Corticosteroid Hormone Receptor Agonists

Corticosteroid

Dermatitis, Atopic

Facial Dermatoses

Foot Dermatoses

Hand Dermatoses

Inflammation

Leg Dermatoses

Pruritus

Psoriasis

Scalp Dermatoses

<section class="Section" data-sectioncode="34089-3"><a name="LH114400e485-7402-11df-93f2-0800200c9a66"></a><a name="section-8"></a><h1>11 DESCRIPTION</h1>ILUVIEN is a sterile non-bioerodable intravitreal implant containing 0.19 mg (190 mcg) fluocinolone acetonide in a 36-month sustained-release drug delivery system. ILUVIEN is designed to release fluocinolone acetonide at an initial rate of 0.25 µg/day. ILUVIEN is preloaded into a single-use applicator to facilitate injection of the implant directly into the vitreous. The drug substance is a synthetic corticosteroid, fluocinolone acetonide.The chemical name for fluocinolone acetonide is (6α,11β, 16α)-6,9-difluoro-11,21-dihydroxy-16,17-[(1-methylethylidene)bis-(oxy)]-pregna-1,4-diene-3,20-dione. Its chemical structure is:<img alt="iluvien-figure-2" src="iluvien-figure-2.jpg"/>MW 452.50; molecular formula C24H30F206Fluocinolone acetonide is a white or almost white, microcrystalline powder, practically insoluble in water, soluble in methanol, ethanol, chloroform and acetone, and sparingly soluble in ether.Each ILUVIEN consists of a light brown 3.5mm x 0.37mm implant containing 0.19 mg of the active ingredient fluocinolone acetonide and the following inactive ingredients: polyimide tube, polyvinyl alcohol, silicone adhesive and water for injection.</section>

Iluvien

fluocinolone acetonide 0.19 MG Drug Implant

fluocinolone acetonide 0.19 MG Drug Implant [Iluvien]

fluocinolone

fluocinolone acetonide

Psoriasis (PsO)

Psoriatic Arthritis (PsA)

Ankylosing Spondylitis (AS)

Nonradiographic Axial Spondyloarthritis

Taltz

Juvenile Idiopathic Arthritis

Hidradenitis Suppurativa (HS)

Cosentyx

Siliq

Tremfya

Crohn's Disease (CD)

Ulcerative Colitis (UC)

Stelara

Skyrizi

Ilumya

Migraine

Cluster Headache

Migraine Prevention

Emgality

Qulipta

Acute Migraine

Ubrelvy

Nurtec ODT

Vyepti

Aimovig

Ajovy

Breast Cancer: HR+ (HER2-)

Verzenio

Ibrance

Kisqali

Atopic Dermatitis (Eczema)

Cibinqo

Eucrisa

Asthma (injectable)

Asthma OCS Dependent

Nasal Polyposis

Eosinophilic Esophagitis (EoE)

Prurigo Nodularis

Dupixent

Opzelura

Adbry

NSCLC ALK+ OR ROS1+ Disease

Lorbrena

Alecensa

Alunbrig

NSCLC cMET Mutation

Xalkori

Rheumatoid Arthritis (RA)

Xeljanz

Uveitis

Graft Versus Host Disease (GVHD)

Orencia

COVID-19 Treatment

Alopecia Areata

Olumiant

Multiple Sclerosis (MS)

Secondary Progressive Multiple Sclerosis

Zeposia

Rinvoq

Entyvio

Report Adverse Event

Prescribing Information

Pharmacy List 

How To Order Iluvien 

Reimbursement Information

Coverage Authorization Request 

Coverage Authorization Appeals 

AccessPlus Patient Enrollment Form 

AccessPlus Patient Enrollment Form - Spanish

Enroll in Patient Savings Program 

Patient Assistance Program Application

Other HCP Resources 

About Iluvien

Side Effects 

Receiving Iluvien 

Getting Started With Iluvien

Patient Stories 

Patient Brochure 

Patient Brochure - Spanish

Doctor Discussion Guide 

Instructions For Use: Diabetic Macular Edema 